Works matching AU Reck, Martin

Results: 101
    1
    2

    Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2018, v. 23, n. 6, p. 654, doi. 10.1634/theoncologist.2017-0690
    By:
    • von Pawel, Joachim;
    • Spigel, David R.;
    • Ervin, Thomas;
    • Losonczy, György;
    • Barlesi, Fabrice;
    • Juhász, Erzsébet;
    • Anderson, Maria;
    • McCall, Bruce;
    • Wakshull, Eric;
    • Hegde, Priti;
    • Ye, Weilan;
    • Chen, Daniel;
    • Chang, Ilsung;
    • Rhee, Ina;
    • Reck, Martin
    Publication type:
    Article
    3
    4

    RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability.

    Published in:
    Drug Safety, 2022, v. 45, n. 1, p. 45, doi. 10.1007/s40264-021-01127-2
    By:
    • Nadal, Ernest;
    • Horinouchi, Hidehito;
    • Shih, Jin-Yuan;
    • Nakagawa, Kazuhiko;
    • Reck, Martin;
    • Garon, Edward B.;
    • Wei, Yu-Feng;
    • Kollmeier, Jens;
    • Frimodt-Moller, Bente;
    • Barrett, Emily;
    • Lipkovich, Olga;
    • Visseren-Grul, Carla;
    • Novello, Silvia
    Publication type:
    Article
    5
    6
    7

    Comparative evaluation of PD‐L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non‐small cell lung cancer patients.

    Published in:
    Molecular Oncology, 2023, v. 17, n. 5, p. 737, doi. 10.1002/1878-0261.13415
    By:
    • Abdo, Mustafa;
    • Belloum, Yassine;
    • Heigener, David;
    • Welker, Lutz;
    • von Weihe, Sönke;
    • Schmidt, Milena;
    • Heuer‐Olewinski, Nadine;
    • Watermann, Iris;
    • Szewczyk, Marlen;
    • Kropidlowski, Jolanthe;
    • Pereira‐Veiga, Thais;
    • Elmas, Hatice;
    • Perner, Sven;
    • Steurer, Stefan;
    • Wikman, Harriet;
    • Pantel, Klaus;
    • Reck, Martin
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14

    nab -Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+).

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.569715
    By:
    • Morgensztern, Daniel;
    • Dols, Manuel Cobo;
    • Ponce Aix, Santiago;
    • Postmus, Pieter E.;
    • Bennouna, Jaafar;
    • Fischer, Jürgen R.;
    • Juan-Vidal, Oscar;
    • Stewart, David J.;
    • Ardizzoni, Andrea;
    • Bhore, Rafia;
    • Wolfsteiner, Marianne;
    • Reck, Martin;
    • Talbot, Denis;
    • Govindan, Ramaswamy;
    • Ong, Teng Jin
    Publication type:
    Article
    15
    16
    17
    18

    TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities.

    Published in:
    Virchows Archiv: European Journal of Pathology, 2024, v. 485, n. 5, p. 815, doi. 10.1007/s00428-024-03926-1
    By:
    • Möller, Katharina;
    • Gulzar, Tayyaba;
    • Lennartz, Maximilian;
    • Viehweger, Florian;
    • Kluth, Martina;
    • Hube-Magg, Claudia;
    • Bernreuther, Christian;
    • Bawahab, Ahmed Abdulwahab;
    • Simon, Ronald;
    • Clauditz, Till S.;
    • Sauter, Guido;
    • Schlichter, Ria;
    • Hinsch, Andrea;
    • Kind, Simon;
    • Jacobsen, Frank;
    • Burandt, Eike;
    • Frost, Nikolaj;
    • Reck, Martin;
    • Marx, Andreas H.;
    • Krech, Till
    Publication type:
    Article
    19
    20
    21

    Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians.

    Published in:
    Respiration, 2022, v. 101, n. 3, p. 307, doi. 10.1159/000518896
    By:
    • Lommatzsch, Marek;
    • Rabe, Klaus F.;
    • Taube, Christian;
    • Joest, Marcus;
    • Kreuter, Michael;
    • Wirtz, Hubert;
    • Blum, Torsten Gerriet;
    • Kolditz, Martin;
    • Geerdes-Fenge, Hilte;
    • Otto-Knapp, Ralf;
    • Häcker, Brit;
    • Schaberg, Tom;
    • Ringshausen, Felix C.;
    • Vogelmeier, Claus F.;
    • Reinmuth, Niels;
    • Reck, Martin;
    • Gottlieb, Jens;
    • Konstantinides, Stavros;
    • Meyer, Joachim;
    • Worth, Heinrich
    Publication type:
    Article
    22
    23
    24
    25
    26
    27

    Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small-cell lung cancer.

    Published in:
    Current Medical Research & Opinion, 2020, v. 36, n. 10, p. 1667, doi. 10.1080/03007995.2020.1808781
    By:
    • Yoh, Kiyotaka;
    • Atagi, Shinji;
    • Reck, Martin;
    • Garon, Edward B.;
    • Ponce Aix, Santiago;
    • Moro-Sibilot, Denis;
    • Winfree, Katherine B.;
    • Frimodt-Moller, Bente;
    • Zimmermann, Annamaria;
    • Visseren-Grul, Carla;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    28
    29
    30

    In Reply.

    Published in:
    Deutsches Ärzteblatt International, 2023, v. 120, n. 41, p. 3, doi. 10.3238/arztebl.m2023.0198
    By:
    • Reck, Martin;
    • Vogel-Claussen, Jens
    Publication type:
    Article
    31

    Lung Cancer Screening With Low-Dose Computed Tomography.

    Published in:
    Deutsches Ärzteblatt International, 2023, v. 120, n. 23, p. 387, doi. 10.3238/arztebl.m2023.0099
    By:
    • Reck, Martin;
    • Dettmer, Sabine;
    • Kauczor, Hans-Ulrich;
    • Kaaks, Rudolf;
    • Reinmuth, Niels;
    • Vogel-Claussen, Jens
    Publication type:
    Article
    32

    The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC.

    Published in:
    Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01550
    By:
    • Marwitz, Sebastian;
    • Turkowski, Kati;
    • Nitschkowski, Dörte;
    • Weigert, Andreas;
    • Brandenburg, Julius;
    • Reiling, Norbert;
    • Thomas, Michael;
    • Reck, Martin;
    • Drömann, Daniel;
    • Seeger, Werner;
    • Rabe, Klaus F.;
    • Savai, Rajkumar;
    • Goldmann, Torsten
    Publication type:
    Article
    33

    Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42900-4
    By:
    • Lim, Sun Min;
    • Peters, Solange;
    • Ortega Granados, Ana Laura;
    • Pinto, Gustavo dix Junqueira;
    • Fuentes, Christian Sebastián;
    • Lo Russo, Giuseppe;
    • Schenker, Michael;
    • Ahn, Jin Seok;
    • Reck, Martin;
    • Szijgyarto, Zsolt;
    • Huseinovic, Neda;
    • Zografos, Eleftherios;
    • Buss, Elena;
    • Stjepanovic, Neda;
    • O'Donnell, Sean;
    • de Marinis, Filippo
    Publication type:
    Article
    34
    35

    Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors.

    Published in:
    Cancers, 2019, v. 11, n. 6, p. 835, doi. 10.3390/cancers11060835
    By:
    • Janning, Melanie;
    • Kobus, Franca;
    • Babayan, Anna;
    • Wikman, Harriet;
    • Velthaus, Janna-Lisa;
    • Bergmann, Sonja;
    • Schatz, Stefanie;
    • Falk, Markus;
    • Berger, Lars-Arne;
    • Böttcher, Lisa-Marie;
    • Päsler, Sarina;
    • Gorges, Tobias M.;
    • O'Flaherty, Linda;
    • Hille, Claudia;
    • Joosse, Simon A.;
    • Simon, Ronald;
    • Tiemann, Markus;
    • Bokemeyer, Carsten;
    • Reck, Martin;
    • Riethdorf, Sabine
    Publication type:
    Article
    36

    Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.

    Published in:
    Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920951358
    By:
    • Brueckl, Wolfgang M;
    • Reck, Martin;
    • Rittmeyer, Achim;
    • Kollmeier, Jens;
    • Wesseler, Claas;
    • Wiest, Gunther H;
    • Christopoulos, Petros;
    • Tufman, Amanda;
    • Hoffknecht, Petra;
    • Ulm, Bernhard;
    • Reich, Fabian;
    • Ficker, Joachim H;
    • Laack, Eckart
    Publication type:
    Article
    37

    Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.

    Published in:
    Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920951358
    By:
    • Brueckl, Wolfgang M.;
    • Reck, Martin;
    • Rittmeyer, Achim;
    • Kollmeier, Jens;
    • Wesseler, Claas;
    • Wiest, Gunther H.;
    • Christopoulos, Petros;
    • Tufman, Amanda;
    • Hoffknecht, Petra;
    • Ulm, Bernhard;
    • Reich, Fabian;
    • Ficker, Joachim H.;
    • Laack, Eckart
    Publication type:
    Article
    38
    39
    40
    41

    Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 251, doi. 10.1007/s00262-021-02981-w
    By:
    • Budczies, Jan;
    • Kirchner, Martina;
    • Kluck, Klaus;
    • Kazdal, Daniel;
    • Glade, Julia;
    • Allgäuer, Michael;
    • Kriegsmann, Mark;
    • Heußel, Claus-Peter;
    • Herth, Felix J.;
    • Winter, Hauke;
    • Meister, Michael;
    • Muley, Thomas;
    • Goldmann, Torsten;
    • Fröhling, Stefan;
    • Wermke, Martin;
    • Waller, Cornelius F.;
    • Tufman, Amanda;
    • Reck, Martin;
    • Peters, Solange;
    • Schirmacher, Peter
    Publication type:
    Article
    42

    A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 799, doi. 10.1007/s00262-019-02315-x
    By:
    • Sebastian, Martin;
    • Schröder, Andreas;
    • Scheel, Birgit;
    • Hong, Henoch S.;
    • Muth, Anke;
    • von Boehmer, Lotta;
    • Zippelius, Alfred;
    • Mayer, Frank;
    • Reck, Martin;
    • Atanackovic, Djordje;
    • Thomas, Michael;
    • Schneller, Folker;
    • Stöhlmacher, Jan;
    • Bernhard, Helga;
    • Gröschel, Andreas;
    • Lander, Thomas;
    • Probst, Jochen;
    • Strack, Tanja;
    • Wiegand, Volker;
    • Gnad-Vogt, Ulrike
    Publication type:
    Article
    43

    MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage LIB-ILIB NSCLC.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 6, p. 587, doi. 10.1016/j.cllc.2024.06.007
    By:
    • Reck, Martin;
    • Nadal, Ernest;
    • Girard, Nicolas;
    • Filippi, Andrea R.;
    • Martin, Linda W.;
    • Gay, Carl M.;
    • Petersen, Cordula;
    • Gale, Davina;
    • Emeribe, Ugochinyere A.;
    • Georgoulia, Nefeli;
    • Perez, Ignacio E. Diaz;
    • Spicer, Jonathan D.
    Publication type:
    Article
    44

    STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non-Small Cell Lung Cancer With No Actionable Gene Alterations.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 3, p. 274, doi. 10.1016/j.cllc.2023.12.010
    By:
    • Rodriguez-Abreu, Delvys;
    • Bosch-Barrera, Joaquim;
    • Gray, Jhanelle E.;
    • Myung-Ju Ahn;
    • Johnson, Melissa;
    • Xinwei Yu;
    • Mohammad, Saad;
    • Xueying Chen;
    • Todd, Trever;
    • Jongseok Kim;
    • Reck, Martin
    Publication type:
    Article
    45
    46
    47

    Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.

    Published in:
    2018
    By:
    • Hirsch, Fred R.;
    • Kerr, Keith M.;
    • Bunn Jr, Paul A.;
    • Kim, Edward S.;
    • Obasaju, Coleman;
    • Pérol, Maurice;
    • Bonomi, Philip;
    • Bradley, Jeffrey D.;
    • Gandara, David;
    • Jett, James R.;
    • Langer, Corey J.;
    • Natale, Ronald B.;
    • Novello, Silvia;
    • Paz-Ares, Luis;
    • Ramalingam, Suresh S.;
    • Reck, Martin;
    • Reynolds, Craig H.;
    • Smit, Egbert F.;
    • Socinski, Mark A.;
    • Spigel, David R.
    Publication type:
    journal article
    48

    Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.

    Published in:
    2018
    By:
    • Ramalingam, Suresh S.;
    • Pérol, Maurice;
    • Reck, Martin;
    • Kowalyszyn, Ruben Dario;
    • Gautschi, Oliver;
    • Kimmich, Martin;
    • Eun Kyung Cho;
    • Czyzewicz, Grzegorz;
    • Grigorescu, Alexandru;
    • Karaseva, Nina;
    • Dakhil, Shaker;
    • Pablo Lee;
    • Zimmerman, Annamaria;
    • Sashegyi, Andreas;
    • Alexandris, Ekaterine;
    • Carter, Gebra Cuyun;
    • Winfree, Katherine B.;
    • Garon, Edward B.;
    • Cho, Eun Kyung;
    • Lee, Pablo
    Publication type:
    journal article
    49
    50